Embriopatía por isotretinoína: Un daño evitable

dc.creatorTroncoso Sch., Mónica
dc.creatorRojas H., Carla
dc.creatorBravo Castro, Eduardo
dc.date.accessioned2010-01-22T14:01:49Z
dc.date.available2010-01-22T14:01:49Z
dc.date.created2010-01-22T14:01:49Z
dc.date.issued2008-06
dc.identifierREVISTA MEDICA DE CHILE, Volume: 136, Issue: 6, Pages: 763-766, 2008
dc.identifier0034-9887
dc.identifierhttps://repositorio.uchile.cl/handle/2250/128288
dc.description.abstractRetinoic acid is a widely used drug in the treatment of cystic acne. It has teratogenic effects that depend on the gestational period in which it is used. We report a seven months old female whose mother was exposed to retinoic acid in both pregestational and gestational periods. She had a retardation of psychomotor development and a brain MRI showed frontal atrophy and a malformation of the posterior fossa. We discuss the mechanisms of the teratogenic effects of retinoic acid
dc.languagees
dc.publisherSOC MEDICA SANTIAGO
dc.subjectAbnormalities, drug-induced
dc.titleEmbriopatía por isotretinoína: Un daño evitable
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución